CBD Treatment Offers Hope for Autism Patients
CBD as a treatment for autism offers families hope. Families of children with autism spectrum disorder (ASD) often face a difficult reality; therapies can help, but there are still no established medications that treat autism’s core symptoms, such as social communication challenges and repetitive behaviors. There are drugs that are used for related issues like irritability or aggression, but they often have significant side effects and limited benefit. New research is drawing attention! Dr. Adi Aran, a pediatric neurologist at Shaare Zedek Medical Center in Jerusalem, had been studying whether CBD based treatment can help children with ASD.
In a randomized, double-blind, placebo-controlled trial involving 150 children and adolescents ages 5 to 21, researchers tested two cannabis-based treatments: a whole-plant extract containing cannabidiol (CBD) and tetrahydrocannabinol (THC) in a 20:1 ratio, and a purified version of CBD and THC in the same ratio. A third group received placebo.
Results of the Study
The results were promising, though not definitive. On one major clinician-rated measure, about 49% of children receiving the whole-plant extract were rated as “much improved” or “very much improved,” compared with 21% of those taking placebo. Researchers also found signs of improvement in some autism-related symptoms, including social responsiveness. Importantly, there were no treatment-related serious adverse events reported. See other studies and their results.
How does CBD Work
CBD and THC affect the body’s endocannabinoid system, a cell-signaling network involved in brain function, mood, and behavior. Researchers suspect this system may play a role in autism. Studies have found lower endocannabinoid levels in children with ASD. CBD is interesting because it does not get a person high and may have anti-anxiety, antipsychotic, and neuroprotective properties. A parent could feel safe having their child eat a piece of CBD-infused candy or rubbing CBD-infused lotion on their child’s skin.
Cautionary Findings
The findings should still be viewed with caution. Not every measured outcome improved. The study had limitations, including crossover effects that complicated part of the analysis. The treatment also included THC, which can have risks in young people, especially at higher doses.
Even so, the study adds to growing evidence that cannabinoids deserve further investigation in autism care. Dr. Aran is now planning a follow-up trial focused on younger children ages 4 to 12, using a cannabinoid-based treatment combined with other supportive compounds in what he calls a “neuroprotective cocktail.”
Conclusion
In conclusion, for families affected by autism, this research does not offer a cure. But it may open a new door for managing difficult behavioral symptoms—and perhaps, one day, improving quality of life in meaningful ways. We’re going to keep an eye out for his follow-up trial results!
